Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Todd Neale

June 22, 2015

News Daily News

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

May 12, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

News Daily News

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

Todd Neale

February 22, 2015

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

Advertisement

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

TCTMD’s Top 10 Most Popular Stories for January 2016

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content